Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Hvivo Plc (LSE:HVO) Declines 2.50%: What Is Weighing on Investor Sentiment?

Hvivo Plc — LSE:HVO closed 2.50% lower on 02 November 2026, with the shares at 5.85p after a decrease of 0.15p on the day.

Ishan Mudgal | 02 November 2026

Bloomsbury Publishing Plc (LSE:BMY) Rises 1.39%: Is the Harry Potter Publisher Writing a New Chapter?

LSE:BMY operates two complementary publishing divisions: consumer and special interest publishing, which includes general trade books, children's books and special interest titles; and academic and professional publishing, which provides textbooks, research databases and digital content to universities, libraries and professionals worldwide. The academic division …

Divya Sood | 02 November 2026

Cordiant Digital Infrastructure Ltd (LSE:CORD) Gains 1.47%: Is the Digital Infrastructure Trust Connecting With Investors?

LSE:CORD is a closed-ended investment company that invests in digital infrastructureAssetsin the developed world, including data centres, subsea cables, fibre networks and towers. These assets are characterised by long-term contracted revenues, high barriers to entry and growing demand driven by the increasing digitisation of …

Divya Sood | 02 November 2026

Genomic Health / Genuit Group Plc (LSE:GNC) Gains 1.40%: Is the Sustainable Infrastructure Specialist Picking Up Steam?

LSE:GNC (formerly Polypipe Group) designs and manufactures sustainable water and climate management systems for buildings and infrastructure. Products include drainage, rainwater management, underfloor heating, ventilation and above-ground waste systems. The group serves new build residential, commercial and civil infrastructure markets, with products specified by …

Divya Sood | 02 November 2026

HUTCHMED (LSE:HCM) in Focus on London Stock Exchange: Regulatory filings accepted for review Puts Next Catalyst in View

• The announcement matters most through its potential effect on clinical milestones, regulatory review and development spending.

Ankur Sharma | 02 November 2026

IXICO (LSE:IXI) in Focus on London Stock Exchange: £2.7 million Phase 3 clinical contract Puts Next Catalyst in View

• The announcement matters most through its potential effect on clinical milestones, regulatory review and development spending.

Ankur Sharma | 02 November 2026

Avacta Group (LSE:AVCT) in Focus on London Stock Exchange: Healthcare investor conference announcement Puts Next Catalyst in View

• The announcement matters most through its potential effect on clinical milestones, regulatory review and development spending.

Ankur Sharma | 02 November 2026

Verici Dx (LSE:VRCI) completes £8.75m placing and WRAP retail offer as 2.69bn shares are admitted

Verici Dx (LSE:VRCI) plc, the AIM-quoted developer of clinical diagnostics for organ transplantation, confirmed on 30 October 2026 that its placing and WRAP retail offer had completed. The fundraising generated gross proceeds of £8.75 million and net proceeds of £8.13 million, according to the …

Ankur Sharma | 02 November 2026

EDX Medical Group (LSE:EDX) appoints former Kymab co-founder Professor Michael Owen as chair

EDX Medical Group (LSE:EDX) plc, the AIM-quoted digital diagnostics company, said on 30 October 2026 that Professor Michael John Owen has been appointed non-executive Chairman, effective immediately.

Ankur Sharma | 02 November 2026

Genus (LSE:GNS) in Focus: FTSE 250 Investors Weigh the Next Turning Point

The FTSE 250 context matters because benchmark flows can influenceDemandfor listed shares, particularly when investors rotate between domestic cyclicals, defensives and businesses with international revenues. However, anindexlabel should not be confused with a company catalyst. Price movements can reflect broad positioning, currency expectations and …

Ankur Sharma | 02 November 2026
Support

Hi! How can we help you today?

Loading…